您当前的位置:
首页 >
文章列表页 >
Analysis of factors influencing poor efficacy of neoadjuvant therapy and construction of a prediction model for HER-2-positive breast cancer
Medical Journal of Chinese People′s Liberation Army   Vol. 50, Issue 12, Pages: 1499-1507(2025)
Clinical Research | 更新时间:2026-01-07
    • Analysis of factors influencing poor efficacy of neoadjuvant therapy and construction of a prediction model for HER-2-positive breast cancer

      增强出版
    • The latest research reveals the influencing factors of poor neoadjuvant efficacy in HER-2 positive breast cancer, and constructs a prediction model to provide reference for individualized treatment.
    • DOI:10.11855/j.issn.0577-7402.2069.2025.0512    

      CLC: R722.6
    • Received:13 December 2024

      Accepted:16 March 2025

      Published:28 December 2025

    移动端阅览

  • Huang De-Qin,Liu Li-Qun,Chen Jia-Hai,et al.Analysis of factors influencing poor efficacy of neoadjuvant therapy and construction of a prediction model for HER-2-positive breast cancer[J].Medical Journal of Chinese People′s Liberation Army,2025,50(12):1499-1507. DOI: 10.11855/j.issn.0577-7402.2069.2025.0512.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Construction of a risk prediction model for sepsis-associated encephalopathy based on LASSO-logistic regression
Establishment and evaluation of a predictive model for spontaneous peritonitis in HBV-related primary liver cancer
Construction and validation of a risk prediction model for 28-day mortality in patients with sepsis-associated acute kidney injury
Age-period-cohort model analysis and prediction of breast cancer incidence and mortality among Chinese women from 1992 to 2021

Related Author

Huang De-Qin
Chen Jia-Hai
Luo Dan-Feng
Ma Xin-Ying
Xu Shi-Xing
Zhang Xun-Hao
Zhao Wei-Hong
Wang Qi

Related Institution

南开大学医学院
Nankai University School of Medicine
Department of Medical Oncology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China,3.Department of Medical Oncology, the 910th Hospital
Department of Critical Care Medicine, Xijing Hospital, Air Force Medical University
School of Public Health, Dali University, Dali
0